We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Biomagnetic Therapy on Gonarthrosis

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00415662
First Posted: December 25, 2006
Last Update Posted: December 25, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Lausanne Hospitals
  Purpose
In order to assess the effectiveness of biomagnetic therapy (PST) in the treatment of gonarthrosis, we conducted a randomized, double blind controlled clinical trial comparing one group of patients treated with PST and a second group of patients treated with conventional physical therapy.

Condition Intervention
Knee Osteoarthritis Device: Pulsed Signal Therapy (PST)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double

Resource links provided by NLM:


Further study details as provided by University of Lausanne Hospitals:

Study Start Date: June 2002
Estimated Study Completion Date: June 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • at least 35 years old
  • local symptoms over a period of at least one-year
  • persistent symptoms despite non steroidal anti-inflammatory drugs
  • informed consent

Exclusion Criteria:

  • operative treatment in the last six months
  • intra-articular injection in the last four months
  • rheumatic disease
  • homolateral coxarthrosis
  • malignant disorder
  • body mass index greater than 33%
  • pregnancy
  • inability to understand the visual analog scale
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00415662


Locations
Switzerland
HOSR
Lausanne, Switzerland, 1005
Sponsors and Collaborators
University of Lausanne Hospitals
Investigators
Principal Investigator: G Gremion, MD HOSR
  More Information

ClinicalTrials.gov Identifier: NCT00415662     History of Changes
Other Study ID Numbers: HO 07/02
First Submitted: December 22, 2006
First Posted: December 25, 2006
Last Update Posted: December 25, 2006
Last Verified: December 2006

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases